Last reviewed · How we verify
Psychiatric treatment with escitalopram
Psychiatric treatment with escitalopram is a Small molecule drug developed by Klinički Bolnički Centar Zagreb. It is currently in Phase 1 development. Also known as: Intervention II.
At a glance
| Generic name | Psychiatric treatment with escitalopram |
|---|---|
| Also known as | Intervention II |
| Sponsor | Klinički Bolnički Centar Zagreb |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole (NA)
- Neurobiological and Genomic Predictors of Relapse in Depression
- Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
- DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")
- Personalized Escitalopram Dosing in Patients With Depression
- SSRIs and TDCS Enhance Post-stroke Motor Recovery (PHASE3)
- The Recovery of Cardiovascular Patients With Depression (NA)
- Anxiety and Depression in Epilepsy: A Treatment Study (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Psychiatric treatment with escitalopram CI brief — competitive landscape report
- Psychiatric treatment with escitalopram updates RSS · CI watch RSS
- Klinički Bolnički Centar Zagreb portfolio CI
Frequently asked questions about Psychiatric treatment with escitalopram
What is Psychiatric treatment with escitalopram?
Psychiatric treatment with escitalopram is a Small molecule drug developed by Klinički Bolnički Centar Zagreb.
Who makes Psychiatric treatment with escitalopram?
Psychiatric treatment with escitalopram is developed by Klinički Bolnički Centar Zagreb (see full Klinički Bolnički Centar Zagreb pipeline at /company/klini-ki-bolni-ki-centar-zagreb).
Is Psychiatric treatment with escitalopram also known as anything else?
Psychiatric treatment with escitalopram is also known as Intervention II.
What development phase is Psychiatric treatment with escitalopram in?
Psychiatric treatment with escitalopram is in Phase 1.
Related
- Manufacturer: Klinički Bolnički Centar Zagreb — full pipeline
- Also known as: Intervention II
- Compare: Psychiatric treatment with escitalopram vs similar drugs
- Pricing: Psychiatric treatment with escitalopram cost, discount & access